Enveric Biosciences, Inc.
Index- P/E- EPS (ttm)-76.19 Insider Own15.01% Shs Outstand1.06M Perf Week-7.85%
Market Cap7.09M Forward P/E- EPS next Y-14.00 Insider Trans0.00% Shs Float0.77M Perf Month-18.91%
Income-50.30M PEG- EPS next Q-3.83 Inst Own21.10% Short Float21.66% Perf Quarter-24.02%
Sales- P/S- EPS this Y-73.80% Inst Trans-2.61% Short Ratio0.61 Perf Half Y-79.74%
Book/sh1.76 P/B3.79 EPS next Y12.50% ROA- Target Price32.50 Perf Year-92.81%
Cash/sh16.98 P/C0.39 EPS next 5Y- ROE- 52W Range5.90 - 187.00 Perf YTD-85.61%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-96.50% Beta1.36
Dividend %- Quick Ratio8.30 Sales past 5Y- Gross Margin- 52W Low10.78% ATR1.68
Employees23 Current Ratio8.30 Sales Q/Q- Oper. Margin- RSI (14)44.54 Volatility11.20% 19.45%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.58 Prev Close6.69
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume271.65K Price6.54
Recom2.30 SMA20-11.31% SMA50-29.11% SMA200-77.51% Volume59,064 Change-2.30%
Jul-27-22 07:30AM  
Jul-26-22 05:30PM  
Jul-25-22 08:00AM  
Jul-19-22 07:30AM  
Jul-14-22 12:15PM  
Jul-13-22 07:30AM  
Jun-08-22 07:30AM  
May-24-22 04:05PM  
May-17-22 07:30AM  
May-11-22 07:30AM  
May-05-22 07:30AM  
May-03-22 05:13PM  
Apr-29-22 08:35AM  
Apr-25-22 08:35AM  
Apr-06-22 07:30AM  
Mar-31-22 05:02PM  
Mar-29-22 07:30AM  
Mar-15-22 07:30AM  
Mar-03-22 07:30AM  
Mar-01-22 07:30AM  
Feb-17-22 07:30AM  
Feb-15-22 04:05PM  
Feb-11-22 08:30AM  
Feb-08-22 04:45PM  
Jan-18-22 07:30AM  
Jan-06-22 04:01PM  
Dec-06-21 07:30AM  
Nov-29-21 07:30AM  
Nov-18-21 07:30AM  
Nov-09-21 07:09AM  
Nov-08-21 07:30AM  
Oct-26-21 07:30AM  
Oct-18-21 08:35AM  
Oct-15-21 12:52PM  
Oct-11-21 09:25AM  
Oct-07-21 07:30AM  
Oct-05-21 07:30AM  
Sep-20-21 07:00AM  
Sep-17-21 07:00AM  
Sep-09-21 07:30AM  
Aug-18-21 08:00AM  
Aug-02-21 07:00AM  
Jul-08-21 08:00AM  
Jun-28-21 09:00AM  
Jun-25-21 09:00PM  
Jun-07-21 07:00AM  
Jun-05-21 06:12PM  
Jun-04-21 07:00PM  
Jun-03-21 09:00AM  
Jun-02-21 10:00AM  
Jun-01-21 06:57PM  
May-24-21 06:00AM  
May-18-21 07:30AM  
May-12-21 07:30AM  
Apr-19-21 09:00AM  
Apr-14-21 07:30AM  
Apr-12-21 07:30AM  
Apr-01-21 08:01AM  
Mar-18-21 08:00AM  
Mar-17-21 11:00AM  
Mar-16-21 08:21AM  
Mar-15-21 08:00AM  
Mar-10-21 12:34PM  
Feb-25-21 07:00AM  
Feb-12-21 08:30AM  
Feb-09-21 09:27AM  
Jan-21-21 10:35AM  
Jan-19-21 08:30AM  
Jan-15-21 04:01PM  
Jan-12-21 09:00AM  
Jan-05-21 08:30AM  
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.